News

RXRX gains 5.5% in a month on positive pipeline update; long-term hold advised given strong potential of its AI-driven drug discovery platform.
LUCIA pivotal Phase 3 trial enrolled and randomized over 400 patients in seven months, demonstrating continued strong ...
With the wild success of "Kpop Demon Hunters" and the failure of "Elio" sets a new paradigm for animated features.
In this second installment of “Notes From Abroad,” students reflect on how their summer journeys, made possible by UC San ...
Bitcoin price slips after a $2.25B whale drop. But a new token, $TLD, is quickly rising as one of the best crypto to buy now.
Rule changes for Energy Department grants to schools are primed to alter policies. Other federal agencies could be next.
Recursion Pharmaceuticals RXRX and Relay Therapeutics RLAY are pioneering the use of artificial intelligence (AI) in drug ...
Immediate interventions including bridge and preventive therapies for new daily persistent headache in juveniles are likely ...
McKenna shocked the hockey world by opting to leave Canadian junior hockey for Penn State University's men's hockey program.
Nanoscope Therapeutics begins rolling submission of BLA to US FDA for gene-agnostic therapy, MCO-010 to treat retinitis pigmentosa: Dallas, Texas Wednesday, July 16, 2025, 14:30 H ...
Salesforce reached 1 million AI-powered customer conversations, showcasing breakthroughs in enterprise automation, AI empathy, and next-generation customer service.
DALLAS, TX, USA I July 14, 2025 I Nanoscope Therapeutics Inc., a biotechnology company committed to developing and commercializing novel gene-agnostic ...